rs189611387

Variant summary

Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PP3_ModerateBP6_Very_StrongBS1BS2

The NM_182914.3(SYNE2):​c.18039-5T>A variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00292 in 1,614,132 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0020 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0030 ( 7 hom. )

Consequence

SYNE2
NM_182914.3 splice_region, splice_polypyrimidine_tract, intron

Scores

2
Splicing: ADA: 0.9997
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.923
Variant links:
Genes affected
SYNE2 (HGNC:17084): (spectrin repeat containing nuclear envelope protein 2) The protein encoded by this gene is a nuclear outer membrane protein that binds cytoplasmic F-actin. This binding tethers the nucleus to the cytoskeleton and aids in the maintenance of the structural integrity of the nucleus. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
ESR2 (HGNC:3468): (estrogen receptor 2) This gene encodes a member of the family of estrogen receptors and superfamily of nuclear receptor transcription factors. The gene product contains an N-terminal DNA binding domain and C-terminal ligand binding domain and is localized to the nucleus, cytoplasm, and mitochondria. Upon binding to 17beta-estradiol or related ligands, the encoded protein forms homo- or hetero-dimers that interact with specific DNA sequences to activate transcription. Some isoforms dominantly inhibit the activity of other estrogen receptor family members. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been fully characterized. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -14 ACMG points.

PP3
Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF. Scorers claiming Uncertain: max_spliceai. No scorers claiming Benign.
BP6
Variant 14-64202796-T-A is Benign according to our data. Variant chr14-64202796-T-A is described in ClinVar as [Likely_benign]. Clinvar id is 193771.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-64202796-T-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00198 (301/152254) while in subpopulation NFE AF= 0.00318 (216/68010). AF 95% confidence interval is 0.00283. There are 2 homozygotes in gnomad4. There are 128 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 301 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SYNE2NM_182914.3 linkuse as main transcriptc.18039-5T>A splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant ENST00000555002.6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SYNE2ENST00000555002.6 linkuse as main transcriptc.18039-5T>A splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant 1 NM_182914.3 P4Q8WXH0-2

Frequencies

GnomAD3 genomes
AF:
0.00198
AC:
301
AN:
152138
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000459
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00203
Gnomad ASJ
AF:
0.00605
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000829
Gnomad FIN
AF:
0.000283
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00318
Gnomad OTH
AF:
0.00191
GnomAD3 exomes
AF:
0.00235
AC:
590
AN:
251462
Hom.:
0
AF XY:
0.00226
AC XY:
307
AN XY:
135900
show subpopulations
Gnomad AFR exome
AF:
0.000677
Gnomad AMR exome
AF:
0.00283
Gnomad ASJ exome
AF:
0.00595
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00131
Gnomad FIN exome
AF:
0.000370
Gnomad NFE exome
AF:
0.00316
Gnomad OTH exome
AF:
0.00212
GnomAD4 exome
AF:
0.00302
AC:
4419
AN:
1461878
Hom.:
7
Cov.:
32
AF XY:
0.00303
AC XY:
2206
AN XY:
727236
show subpopulations
Gnomad4 AFR exome
AF:
0.000538
Gnomad4 AMR exome
AF:
0.00259
Gnomad4 ASJ exome
AF:
0.00566
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000951
Gnomad4 FIN exome
AF:
0.000431
Gnomad4 NFE exome
AF:
0.00337
Gnomad4 OTH exome
AF:
0.00329
GnomAD4 genome
AF:
0.00198
AC:
301
AN:
152254
Hom.:
2
Cov.:
32
AF XY:
0.00172
AC XY:
128
AN XY:
74448
show subpopulations
Gnomad4 AFR
AF:
0.000457
Gnomad4 AMR
AF:
0.00203
Gnomad4 ASJ
AF:
0.00605
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000829
Gnomad4 FIN
AF:
0.000283
Gnomad4 NFE
AF:
0.00318
Gnomad4 OTH
AF:
0.00189
Alfa
AF:
0.00228
Hom.:
0
Bravo
AF:
0.00231
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00349
EpiControl
AF:
0.00480

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely benign, criteria provided, single submitterclinical testingAthena DiagnosticsFeb 28, 2018- -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJun 01, 2024SYNE2: BS1, BS2 -
Emery-Dreifuss muscular dystrophy 5, autosomal dominant Benign:2
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 30, 2024- -
not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jul 10, 2015- -
SYNE2-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesJun 27, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.70
CADD
Benign
15
DANN
Benign
0.71

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.97
SpliceAI score (max)
0.40
Details are displayed if max score is > 0.2
DS_AL_spliceai
0.40
Position offset: 5

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs189611387; hg19: chr14-64669514; API